Despite
the isolation of hundreds of bioactive isocyanides from
terrestrial fungi and bacteria as well as marine organisms, the isocyanide
functionality has so far received little attention from a medicinal
chemistry standpoint. The widespread tenet that isocyanides are chemically
and metabolically unstable has restricted bioactivity studies to their
antifouling properties and technical applications. In order to confirm
or refute this idea, the hepatic metabolism of six model isocyanides
was investigated. Aromatic and primary isocyanides turned out to be
unstable and metabolically labile, but secondary and tertiary isocyanides
resisted metabolization, showing, in some cases, cytochrome P450 inhibitory
properties. The potential therefore exists for the secondary and tertiary
isocyanides to qualify them as pharmacophore groups, in particular
as war-heads for metalloenzyme inhibition because of their potent
metal-coordinating properties.